Mechanisms and interventions in peritoneal fibrosis

Area of Science:

• Nephrology
• Cell Biology
• Pathology

Background:

• Peritoneal dialysis (PD) is a vital treatment for end-stage kidney disease (ESKD).
• Long-term PD can lead to detrimental functional and structural changes in the peritoneal membrane.
• Peritoneal fibrosis is a significant complication, often linked to chronic inflammation and factors like transforming growth factor β1 (TGF-β1).

Purpose of the Study:

• To review the mechanisms underlying peritoneal fibrosis in PD patients.
• To consolidate findings from in vitro and in vivo studies on peritoneal fibrosis.
• To discuss current and future therapeutic interventions for peritoneal fibrosis.

Main Methods:

• Literature review of in vitro and in vivo studies.
• Analysis of factors contributing to peritoneal fibrosis.
• Synthesis of information on therapeutic strategies.

Main Results:

• Inflammatory cytokines, particularly TGF-β1, are key drivers of peritoneal fibrosis.
• Chronic inflammation in the peritoneal cavity contributes to membrane alterations.
• Various factors contribute to the development of fibrosis over time.

Conclusions:

• Understanding the mechanisms of peritoneal fibrosis is crucial for PD patient management.
• Targeting inflammatory pathways and TGF-β1 may offer therapeutic benefits.
• Further research into interventions is needed to improve long-term PD outcomes.